Shawn M. Carter
Online Content Editor at Nephrology News & Issues
Deputy editor, Forbes Health (@healthonforbes) Previously: @CNBC/@FoxBusiness/@GoHealio. Views, my own. Reach out at [email protected].
Articles
-
1 week ago |
healio.com | Shawn M. Carter
Key takeaways: Autosomal dominant PKD prevalence was highest in women. Black and non-Hispanic patients also had high rates of the condition. BOSTON — Autosomal dominant polycystic kidney disease rates in the Military Health System are comparable to the general population, but with variability among certain groups, according to a speaker.
-
1 week ago |
healio.com | Shawn M. Carter |Richard Smith
Key takeaways:Researchers found a notable interaction based on patients' prior history of kidney stones. Hypokalemia was more common for patients on chlorthalidone regardless of stone history. BOSTON — Long-acting diuretic chlorthalidone may increase the risk for kidney stones in adults who have previously had them, according to findings presented at the National Kidney Foundation Spring Clinical Meetings.
-
1 week ago |
healio.com | Shawn M. Carter |Richard Smith
Key takeaways:The NKF continues to support policies aimed at prevention, detection and access. NKF has educated 15,000 individuals and supported 7,000 people with mentorships. BOSTON — The National Kidney Foundation Spring Clinical Meetings opened its 75th annual event with a clear message: Enhance patient care by advancing awareness.
-
3 weeks ago |
healio.com | Shawn M. Carter |Gina Brockenbrough
Key takeaways: Risk for cardiovascular death increased with disease stage, but risk was similar for stages 0 and 1. Survival time was reduced by about 8.1 months for stage 4 vs. stage 0. Higher stages of cardiovascular-kidney-metabolic syndrome may correlate to increased risk of cardiovascular mortality, according to a longitudinal study of U.S. adults.
-
3 weeks ago |
healio.com | Shawn M. Carter |Richard Smith
Key takeaways: The End-Stage Renal Disease Treatment Choices model is a mandatory value-based care program from CMS. The model is intended to encourage home dialysis use and transplantation. LAS VEGAS — The CMS End-Stage Renal Disease Treatment Choices model was designed to offer optimal care while cutting Medicare expenses, but policy may not always have the intended effect, according to a speaker.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- No
RT @jawsome_jem: Aaaannnnddd! My @hulu_support live is down and ruining @SharkWeek!!! Get your act together, #Hulu!!! I need my sharks!! 😤…
RT @Ciggydman: Anybody else’s Hulu down? Can’t watch live tv? @Hulu
RT @Nephronline: Living conditions in these 8 US states 📍 pose a novel risk of #chronickidneydisease. https://t.co/YCG27EChvU